ImmunityBio Inc. Share Price Today: Live Updates & Key Insights
ImmunityBio Inc. share price today is $8.55, up -3.97%. The stock opened at $8.96 against the previous close of $8.82, with an intraday high of $9.32 and low of $8.41.
ImmunityBio Inc. Share Price Chart
ImmunityBio Inc.
ImmunityBio Inc. Share Price Performance
ImmunityBio Inc. Institutional Holdings
ImmunityBio Inc. Market Status
ImmunityBio Inc. Fundamentals
Market Cap 8708.10 M
PB Ratio 0.0
PE Ratio 0.0
Enterprise Value 9003.92 M
Total Assets 501.90 M
Volume 31639947
ImmunityBio Inc. Company Financials
About ImmunityBio Inc. & investment objective
Company Information ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.
Organisation Biotechnology
Employees 684
Industry Biotechnology
CEO Mr. Richard Gerald Adcock
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ImmunityBio Inc. FAQs
What is the share price of ImmunityBio Inc. today?
The current share price of ImmunityBio Inc. is $8.55.
Can I buy ImmunityBio Inc. shares in India?
Yes, Indian investors can buy ImmunityBio Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy ImmunityBio Inc. shares in India?
You can easily invest in ImmunityBio Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ImmunityBio Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ImmunityBio Inc..
Can I buy fractional shares of ImmunityBio Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ImmunityBio Inc.?
ImmunityBio Inc. has a market cap of $8708.10 M.
In which sector does ImmunityBio Inc. belong?
ImmunityBio Inc. operates in the Biotechnology sector.
What documents are required to invest in ImmunityBio Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of ImmunityBio Inc.?
The PE ratio of ImmunityBio Inc. is N/A and the PB ratio is N/A.